Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide.
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
Singapore – 19 September 2023 - Novotech, the leading Asia Pacific centred biote
Read more